The overexpressed PD-L1 on tumor cells serve to interact with the immune checkpoint molecule, PD-1, on activated T cells to cause dysfunction and exhaustion of cytotoxic T cells, thus escaping the immune surveillance to prevent the clearance of tumor cells. Here, PDCD1 is linked to neoplasm.